COMMUNIQUÉS West-GlobeNewswire

Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
08/07/2026
July 16 in Boston, management will engage with investors and industry participants at the healthcare-focused event covering neuropsychiatry, neurodegeneration, neuromuscular disease, ophthalmology, and neuroimmunology [...]
Shopify to Announce Second-Quarter 2026 Financial Results
08/07/2026
Internet, Everywhere, July 08, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) plans to announce financial results for the quarter ended June 30, 2026 before markets open on Wednesday, August 5, 2026. Shopify’ [...]
J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation
08/07/2026
TAICHUNG CITY, Taiwan, July 08, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today announced that it plans to implement a 1-for-5 share consolidation of its Class A [...]
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
08/07/2026
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesting improved muscle composition All four [...]
Angelini Ventures Invests in Handspring Health's $19 Million Series B to Expand Access to High-Quality Mental Health Care for Children and Families
08/07/2026
Funding will support nationwide expansion of Handspring's clinician-led, evidence-based care model and technology platform for pediatric mental health care Angelini Ventures’ Sarah Fox joins Handspring's Board as an [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
08/07/2026
Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- [...]
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
08/07/2026
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX's Detection-Analysis-Response strategy through security systems, fire detection, access [...]
Ontario’s Lung Cancer Screening Program Ranks Among World’s Best, but Half of Patients Are Still Diagnosed at Advanced Stages, New Report Finds
08/07/2026
Lung Health Foundation’s landmark baseline report shows a system with exceptional foundations – and critical blind spots in equity, patient experience, and access that could determine whether Ontario meets the Pan- [...]
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
08/07/2026
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care
08/07/2026
The board features stroke experts from the US, UK, Canada, Spain, Nigeria and Australia CAMBRIDGE, United Kingdom, July 08, 2026 (GLOBE NEWSWIRE) -- A Cambridge-founded medtech company developing rapid blood tests for [...]
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
08/07/2026
Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions, will be appointed as Chief Business Officer Charles Carter promoted to Chief Financial Officer, reflecting his strong [...]
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
08/07/2026
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as Tensive approaches pivotal clinical and regulatory milestones for its [...]
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08/07/2026
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk
08/07/2026
Trimoryn issues a 2026 supplement facts and consumer safety update covering its weight management support formula, ingredient amounts, suggested use, side effects risk considerations, customer support details, and 60- [...]
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
08/07/2026
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer. Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake [...]
AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins
08/07/2026
NEURIED, Germany and NESLE, France, July 08, 2026 (GLOBE NEWSWIRE) -- AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe ( [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08/07/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
08/07/2026
Novo Nordisk s’apprête à mener une évaluation interne non exclusive des implants à base de sémaglutide élaborés par Vivani ALAMEDA, Californie, 08 juill. 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq : VANI) (« [...]

Pages